APA

Wang Y., Xu B., Zhu L., Lou K., Chen Y., Zhao X., Wang Q., Xu L., Guo X., Ji L., Cui Y. & Fang Y. (20180126). Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus. : Clinical drug investigation.

Chicago

Wang Yitong, Xu Bingfeng, Zhu Lixia, Lou Kun, Chen Yingli, Zhao Xia, Wang Qian, Xu Ling, Guo Xiaohui, Ji Linong, Cui Yimin and Fang Yi. 20180126. Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus. : Clinical drug investigation.

Harvard

Wang Y., Xu B., Zhu L., Lou K., Chen Y., Zhao X., Wang Q., Xu L., Guo X., Ji L., Cui Y. and Fang Y. (20180126). Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus. : Clinical drug investigation.

MLA

Wang Yitong, Xu Bingfeng, Zhu Lixia, Lou Kun, Chen Yingli, Zhao Xia, Wang Qian, Xu Ling, Guo Xiaohui, Ji Linong, Cui Yimin and Fang Yi. Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus. : Clinical drug investigation. 20180126.